Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Blanchon

Showing results (41-50 of 58) with videos related to

Pageof 6
Sort By:
Le Poumon Et Le Coeur|January 1, 1979
[Partial anomalous pulmonary venous drainage of the left lung into the innominate vein (author's transl)]F Blanchon, A Chatel, B Milleron, et al.
Cancer|November 1, 1985
A prospective study of detorubicin in malignant mesotheliomaN Colbert, J M Vannetzel, V Izrael, et al.
Revue Des Maladies Respiratoires|November 8, 2017
[First treatment strategies in the 2 years following lung cancer diagnosis. ESCAP-2011-CPHG, a real-life study carried out in French general hospitals]M Grivaux, F Goupil, B Asselain, et al.
Revue Des Maladies Respiratoires|January 14, 2003
[Epidemiologic of primary bronchial carcinoma management in the general French hospital centers]F Blanchon, M Grivaux, T Collon, et al.
Revue Des Maladies Respiratoires|September 28, 2011
Five-year survival for lung cancer patients managed in general hospitalsM Grivaux, M Zureik, L Marsal, et al.
Revue Des Maladies Respiratoires|February 13, 2009
[Five year survival for lung cancer patients managed in general hospitals]M Grivaux, M Zureik, L Marsal, et al.
Revue De Pneumologie Clinique|December 21, 2010
[Study KBP-2010-CPHG: inclusion of new cases of primary lung cancer diagnosed in general hospital pneumology departments between 1st January and 31 December 2010]M Grivaux, C Locher, P Bombaron, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 22, 2002
Phase II randomized multicenter study evaluating a treatment regimen alternating docetaxel and cisplatin-vinorelbine with a cisplatin-vinorelbine control group in patients with stage IV non-small-cell lung cancer: GFPC 97.01 studyM Pérol, H Léna, P Thomas, et al.
Revue Des Maladies Respiratoires|June 22, 2006
[Cohort KBP-2000-CPHG: Evaluation of factors influencing survival in lung cancer]F Blanchon, M Grivaux, M Zureik, et al.
Revue Des Maladies Respiratoires|October 11, 2007
[Acute exacerbations of COPD admitted to hospital: predictive factors of 3 year mortality]J Piquet, C Maurer, H Barbieux, et al.
Pageof 6

Showing results (41-50 of 58) with videos related to

Sort By:
Pageof 6
Le Poumon Et Le Coeur|January 1, 1979
[Partial anomalous pulmonary venous drainage of the left lung into the innominate vein (author's transl)]F Blanchon, A Chatel, B Milleron, et al.
Cancer|November 1, 1985
A prospective study of detorubicin in malignant mesotheliomaN Colbert, J M Vannetzel, V Izrael, et al.
Revue Des Maladies Respiratoires|November 8, 2017
[First treatment strategies in the 2 years following lung cancer diagnosis. ESCAP-2011-CPHG, a real-life study carried out in French general hospitals]M Grivaux, F Goupil, B Asselain, et al.
Revue Des Maladies Respiratoires|January 14, 2003
[Epidemiologic of primary bronchial carcinoma management in the general French hospital centers]F Blanchon, M Grivaux, T Collon, et al.
Revue Des Maladies Respiratoires|September 28, 2011
Five-year survival for lung cancer patients managed in general hospitalsM Grivaux, M Zureik, L Marsal, et al.
Revue Des Maladies Respiratoires|February 13, 2009
[Five year survival for lung cancer patients managed in general hospitals]M Grivaux, M Zureik, L Marsal, et al.
Revue De Pneumologie Clinique|December 21, 2010
[Study KBP-2010-CPHG: inclusion of new cases of primary lung cancer diagnosed in general hospital pneumology departments between 1st January and 31 December 2010]M Grivaux, C Locher, P Bombaron, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 22, 2002
Phase II randomized multicenter study evaluating a treatment regimen alternating docetaxel and cisplatin-vinorelbine with a cisplatin-vinorelbine control group in patients with stage IV non-small-cell lung cancer: GFPC 97.01 studyM Pérol, H Léna, P Thomas, et al.
Revue Des Maladies Respiratoires|June 22, 2006
[Cohort KBP-2000-CPHG: Evaluation of factors influencing survival in lung cancer]F Blanchon, M Grivaux, M Zureik, et al.
Revue Des Maladies Respiratoires|October 11, 2007
[Acute exacerbations of COPD admitted to hospital: predictive factors of 3 year mortality]J Piquet, C Maurer, H Barbieux, et al.
Pageof 6